Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.0512 | 0.223 |
Toxoplasma gondii | ribonuclease HI protein | 0.0368 | 0.2266 | 0.5 |
Schistosoma mansoni | phosphoglucomutase | 0.0368 | 0.2266 | 0.2266 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0147 | 0.0576 | 0.2542 |
Trypanosoma brucei | ingi protein (ORF1) | 0.04 | 0.2505 | 0.2505 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.0368 | 0.2266 | 0.5 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0368 | 0.2266 | 1 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0368 | 0.2266 | 0.5 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0403 | 0.2527 | 0.2527 |
Echinococcus granulosus | ribonuclease H1 | 0.0368 | 0.2266 | 0.8702 |
Entamoeba histolytica | hypothetical protein | 0.017 | 0.0754 | 0.6931 |
Schistosoma mansoni | phosphoglucomutase | 0.0368 | 0.2266 | 0.2266 |
Trypanosoma brucei | unspecified product | 0.04 | 0.2505 | 0.2505 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0189 | 0.0893 | 0.3941 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0214 | 0.1088 | 0.4801 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0214 | 0.1088 | 1 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0214 | 0.1088 | 0.4801 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.0368 | 0.2266 | 1 |
Trypanosoma brucei | ribonuclease H1 | 0.0368 | 0.2266 | 0.2266 |
Schistosoma mansoni | phosphoglucomutase | 0.0368 | 0.2266 | 0.2266 |
Leishmania major | ribonuclease H1, putative | 0.0368 | 0.2266 | 0.5 |
Brugia malayi | RNase H family protein | 0.0368 | 0.2266 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0368 | 0.2266 | 0.5 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.017 | 0.0754 | 0.6931 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0214 | 0.1088 | 0.4801 |
Giardia lamblia | Ribonuclease H | 0.0368 | 0.2266 | 1 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0147 | 0.0576 | 0.2542 |
Brugia malayi | RNase H family protein | 0.0368 | 0.2266 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.04 | 0.2505 | 0.2505 |
Echinococcus multilocularis | ribonuclease H1 | 0.0368 | 0.2266 | 0.8702 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0368 | 0.2266 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.04 | 0.2505 | 0.2505 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0214 | 0.1088 | 0.4801 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0214 | 0.1088 | 0.4801 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0359 | 0.2194 | 1 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0403 | 0.2527 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0139 | 0.0512 | 0.2259 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0095 | 0.0178 | 0.1637 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0403 | 0.2527 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.1382 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0208 | 0.1039 | 0.9555 |
Brugia malayi | RNase H family protein | 0.0368 | 0.2266 | 1 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.04 | 0.2505 | 0.2505 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0214 | 0.1088 | 0.4801 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.